According to Andrew Huberman, psychedelics can be considered healthy and helpful in certain contexts. He mentions that there is clinical data showing a 65% plus success rate for treating otherwise intractable and untreatable suicidal depression with psychedelics like psilocybin. Additionally, he discusses the emerging science around psychedelics and how pharmaceutical companies are interested in creating non-psychedelic psychedelics to develop new antidepressants. Huberman's perspective suggests that psychedelics can have positive effects on mental health.

Andrew Huberman's experience with psychedelics is not mentioned in the provided context.

According to Andrew Huberman, scientists hung around Jeffrey Epstein because he was providing their laboratories with significant amounts of money that they didn't have to go through the typical grant-writing process for. Epstein understood social engineering and recognized that rich people can get almost anything they want except for controlling their reputation, which requires other people's perceptions. By offering laboratories large sums of money, Epstein made himself an attractive figure to scientists, who had blinders on and were not fully considering the implications of associating with him. Additionally, Epstein's ability to gather rich and influential individuals in his social circles made scientists feel comfortable in his presence. It was a combination of financial support and the allure of being among other renowned and successful individuals that drew scientists to him.

According to Andrew Huberman, scientists hung around Jeffrey Epstein because he was providing their laboratories with money that they didn't have to write grants for. Epstein understood social engineering and knew that by offering laboratories significant funding, he was able to attract scientists to his circle. The workload to maintain the grants offered by Epstein was immense, but for a laboratory, it was equivalent to receiving four national institutes of health grants per year. Scientists were drawn to the possibility of getting funding and had blinders on when it came to the implications of associating with Epstein. Additionally, Epstein's ability to gather rich and respected individuals in the same room made scientists feel comfortable being in his presence. Epstein's social engineering tactics made it seem fine for scientists to be associated with him, despite his sinister and diabolical nature. (Joe Rogan Experience, "Andrew Huberman Explains Why Scientists Hung Around Jeffrey Epstein")

According to Andrew Huberman, psychedelics have shown significant success in treating mental health conditions such as intractable, untreatable suicidal depression. He mentions that there is clinical data showing a success rate of 65% or higher for treating depression with psychedelics. He also mentions that these substances have been found to be one of the most effective psychiatric interventions, capable of changing the contents of one's head and leading to a rethinking of mortality. Huberman's description highlights the potential of psychedelics in healing individuals who are suffering from psychiatric illnesses.

"65% plus success rate for what would otherwise be intractable, untreatable suicidal depression. Incredible."

According to the transcript, Andrew Huberman, a guest on the show, discusses the success rate of treating intractable, untreatable suicidal depression with psychedelics. He mentions that the clinical data is showing a 65% plus success rate for treating such depression with psychedelics, which he finds incredible. He specifically mentions his own laboratory's research on high dose psilocybin, guided sessions, and the treatment of anorexia, ADHD, and depression with very high success. He also mentions another lab at Stanford University that is running studies with Veteran Solutions, using Ibogaine DMT in tandem, and getting tremendously positive results for individuals who are heading towards suicidal depression or not feeling quite right. Therefore, based on this information, it can be inferred that Andrew Huberman has a positive perspective on the success rate of treating intractable, untreatable suicidal depression with psychedelics.

According to Andrew Huberman, he states that the clinical data shows a 65% plus success rate for treating intractable, untreatable suicidal depression with psychedelics. He mentions that his own laboratory has been looking at high dose psilocybin treatment for disorders such as anorexia, ADHD, and depression, with very high success. Additionally, Nolan Williams' laboratory at Stanford University has been conducting studies with Veteran Solutions, utilizing Ibogaine and DMT in tandem, and has seen tremendously positive results in individuals who are suffering from severe depression or struggling with readjustment after military service. These findings indicate the potential efficacy of psychedelics in treating psychiatric illnesses. [Quote: "He's saying these things work. The clinical data are showing that. 65% plus success rate for what would otherwise be intractable, untreatable suicidal depression."]